Podcasts about brightfocus

MSNBC/NBC News anchor Richard Lui joins hosts Ron Aaron and Carol Zernial to talk about all things caregiving and caregiving moonshot lunches on this edition of Caregiver SOS. About Richard: Bio: Richard Lui is a veteran journalist with more than 30 years in broadcast journalism, film, technology, and business. Currently an anchor at MSNBC / NBC News and previously with CNN Worldwide, Lui was the first AAPI male to anchor a daily national news show. The team Emmy and Peabody winner is also the longest-serving AAPI male in a national anchor seat, now for almost two decades. Lui has spoken at over 500 community events related to gender, race, and equity in recent years. Considered an authority on race and intersectionality, he is one of the longest-serving correspondents reporting on communities of color. Lui is the author of the bestselling and award-winning book "Enough About Me" from HarperCollins Zondervan, as well as author of the groundbreaking Inclusion@work risk reports released at Davos, SXSW, CES, and Cannes Lions. As a film director he recently released the Oscars- and Grammy-qualifying documentaries ‘Sky Blossom' (2021) and ‘UNCONDITIONAL', (2023) which were honored with an unprecedented series of premieres at the White House, U.S. Congress, United Nations, and European Parliament. Richard's overlapping 20-year business career includes time at Citigroup, Oliver Wyman, Mrs. Fields Cookies, a fintech patent, and launching six tech brands over three business cycles. As an NACD Fellow, he has served on private and NGO boards in the AI, gender equity, and human trafficking sectors. In 2017, Lui founded PRISCA, a not-for-profit organization focused on action-based narrative change. He is a caregiving ambassador for the Alzheimer's Association, AARP, Plan International, BrightFocus, and Caring Across Generations. Hosts Ron Aaron and Carol Zernial, and their guests talk about Caregiving and how to best cope with the stresses associated with it. Learn about "Caregiver SOS" and the "Teleconnection Hotline" programs. Listen every week for deep, inspiring, and helpful caregiving content on Caregiver SOS!

MSNBC/NBC News anchor Richard Lui joins hosts Ron Aaron and Carol Zernial to talk about all things caregiving and caregiving moonshot lunches on this edition of Caregiver SOS. About Richard:   Bio: Richard Lui is a veteran journalist with more than 30 years in broadcast journalism, film, technology, and business. Currently an anchor at MSNBC / NBC News and previously with CNN Worldwide, Lui was the first AAPI male to anchor a daily national news show. The team Emmy and Peabody winner is also the longest-serving AAPI male in a national anchor seat, now for almost two decades. Lui has spoken at over 500 community events related to gender, race, and equity in recent years. Considered an authority on race and intersectionality, he is one of the longest-serving correspondents reporting on communities of color. Lui is the author of the bestselling and award-winning book "Enough About Me" from HarperCollins Zondervan, as well as author of the groundbreaking Inclusion@work risk reports released at Davos, SXSW, CES, and Cannes Lions. As a film director he recently released the Oscars- and Grammy-qualifying documentaries ‘Sky Blossom' (2021) and ‘UNCONDITIONAL', (2023) which were honored with an unprecedented series of premieres at the White House, U.S. Congress, United Nations, and European Parliament. Richard's overlapping 20-year business career includes time at Citigroup, Oliver Wyman, Mrs. Fields Cookies, a fintech patent, and launching six tech brands over three business cycles. As an NACD Fellow, he has served on private and NGO boards in the AI, gender equity, and human trafficking sectors. In 2017, Lui founded PRISCA, a not-for-profit organization focused on action-based narrative change. He is a caregiving ambassador for the Alzheimer's Association, AARP, Plan International, BrightFocus, and Caring Across Generations.  Hosts Ron Aaron and Carol Zernial, and their guests talk about Caregiving and how to best cope with the stresses associated with it. Learn about "Caregiver SOS" and the "Teleconnection Hotline" programs. Listen every week for deep, inspiring, and helpful caregiving content on Caregiver SOS!See omnystudio.com/listener for privacy information.

The event featured guest speaker Preeti Subramanian, PhD, who oversees the Macular Degeneration Research and National Glaucoma Research programs at BrightFocus Foundation. Dr. Subramanian highlighted some of the exciting research currently funded by BrightFocus.

The event featured Joshua Dunaief, M.D., Ph.D., who provided an overview of Age-related Macular Degeneration (AMD) including prevention and treatment. There was specific discussion about overall vision health, new therapies, and which populations are more susceptible to AMD.

The event featured Dr. David S. Liao, a board-certified ophthalmologist at the Retina-Vitreous Associates Medical Group who specializes in the medical and surgical treatment of diseases of the retina and vitreous. Dr. Liao discussed the latest treatments to manage dry AMD and geographic atrophy, recent clinical trials, ways to slow the progression of vision loss, and how to maintain and improve quality of life after the diagnosis of a vision loss disease.

Alan Glazier, OD, is an awarding-winning Maryland optometrist.

In recognition of Age-Related Macular Degeneration Awareness Month, Sue Peschin talks with Martha Taggart, a science writer for the BrightFocus Foundation, about age-related macular degeneration, or AMD, an eye disease that is a leading cause of vision loss in older Americans. Learn more about Martha: https://www.brightfocus.org/bio/martha-snyder-taggart Watch our short films on AMD: https://www.youtube.com/watch?v=TrlWWCd7B4k

The discussion features Edward Marcus, MD, a leading ophthalmologist in New York. Dr. Marcus specializes in medical and surgical management of retinal diseases, including diabetic retinopathy, macular degeneration, and retinal detachment. He also specializes in treating inflammatory and infectious eye diseases.

Dr. Benjamin Kim is Assistant Professor of Ophthalmology at the Hospital of the University of Pennsylvania. His areas of research expertise include age-related macular degeneration, diabetic retinopathy, geographic atrophy, choroidal neovascularization, retinal neovascularization, clinical trials, and retinal imaging.

Ranjoo K. Prasad, O.D., a specialist in low vision rehabilitation at Penn Medicine, is the guest speaker.

The featured expert is Daniel Chao, MD, PhD, who is an Assistant Professor of Ophthalmology at the Shiley Eye Institute. He is a retina surgeon, clinician-scientist, and entrepreneur. Dr. Chao’s clinical focus is in the medical and surgical treatment of retinal diseases with a special interest in macular degeneration and diabetic retinopathy, retinal detachment, and inherited retinal diseases.

Dr. David S. Liao is a board-certified ophthalmologist at the Retina-Vitreous Associates Medical Group in California. He specializes in the medical and surgical treatment of diseases of the retina and vitreous. His main areas of interest include macular degeneration, diabetic retinopathy, disorders of the vitreomacular interface, and retinal detachment repair.

The discussion features Sheldon Rowan, PhD of the USDA Human Nutrition Research Center on Aging, Tufts University. Dr. Rowan’s research examines the impact of dietary carbohydrate quality on age-related macular degeneration.

The guest is Deirdre Johnston, M.B.B.Ch., M.D., who is Assistant Professor, Division of Geriatric Psychiatry and Neuropsychiatry in the Department of Psychiatry at Johns Hopkins School of Medicine, and Medical Director of the PATCH and MIND at Home community-based programs.

The guest is Deirdre Johnston, M.B.B.Ch., M.D., who is Assistant Professor, Division of Geriatric Psychiatry and Neuropsychiatry in the Department of Psychiatry at Johns Hopkins School of Medicine, and Medical Director of the PATCH and MIND at Home community-based programs.

The telephone discussion features Dr. Joshua Dunaief, of the University of Pennsylvania’s Perelman School of Medicine, who specializes in the study of age-related macular degeneration. 

This telephone discussion features Michael B. Gorin, MD, PhD, an ophthalmologist from UCLA who is devoted to research and clinical care of hereditary retinal disorders, especially age-related macular degeneration, retinal dystrophies and other medical retinal conditions.

The guest speaker is Joe Kardine, OTR/L, who is an occupational therapist at Thomas Jefferson University Hospital. Mr. Kardine specializes in treating those with vision and cognitive deficits as well as neurologic rehabilitation.

The guest speaker is Avnish A. Deobhakta, MD, who is an ophthalmologist and Assistant Professor at the Icahn School of Medicine at Mount Sinai in New York NY. 

Yasha Modi, MD is an Assistant Professor in the Department of Ophthalmology at NYU Langone Health and is a vitreoretinal surgeon at Tisch Hospital and the Ambulatory Care Center. He treats people who have diseases that affect the vitreous—a clear substance in the eye—the retina, and the choroid—the layer of the eye containing blood vessels and connective tissue. In addition to caring for patients, he also performs research to understand retinal vascular diseases, including diabetes and vein occlusion, retinal drug toxicity, age-related macular degeneration, and the outcomes of retinal detachment surgery.

The telephone discussion features Emily Y. Chew, MD, who is a retina specialist and is the deputy director of the Division of Epidemiology and Clinical Applications, and the deputy clinical director at the National Eye Institute (NEI), National Institutes of Health (NIH). Dr. Chew has extensive experience in age-related eye diseases, and designing and implementing clinical trials, including the Age-Related Eye Disease Study 2 (AREDS2).

The telephone discussion features Dr. Joshua Dunaief, of the University of Pennsylvania’s Perelman School of Medicine, who specializes in the study of age-related macular degeneration.

The discussion features Milam A. Brantley, Jr., MD, PhD, who is Associate Professor of Ophthalmology and Visual Sciences from Vanderbilt University Medical Center.

The telephone discussion features Belinda Weinberg, OD and Sean Curry, MPH, of the Prevention of Blindness Society of Metropolitan Washington.

The telephone discussion features Belinda Weinberg, OD and Sean Curry, MPH, of the Prevention of Blindness Society of Metropolitan Washington.

Women are almost twice as likely to develop Alzheimer's disease as men. However, this is NOT because they live longer. When we look into the aging brain, males and females experience different timelines. The molecular underpinnings of these sex differences could make a huge impact on our understanding of Alzheimer's disease. Dr. Roberta Diaz Brinton is spearheading research into sex differences in Alzheimer's disease. She works to discover how to protect the aging female brain from these increased risk factors. This episode features another throwback recorded in San Diego, CA, where Connor Wander attended the BrightFocus Alzheimer's Disease Fast Track conference, followed by the Society for Neuroscience annual meeting.   About Dr. Brinton Dr. Roberta Diaz Brinton leads the Center for Innovation in Brain Science at the University of Arizona that studies diseases of aging, Alzheimer’s, Multiple Sclerosis, Parkinson’s and ALS. Dr. Brinton is an internationally recognized expert in the systems biology of Alzheimer’s disease. She is developing the first regenerative therapeutic to regenerate the degenerated brain. Her analysis focuses on the brain at greatest risk for Alzheimer’s: the aging female brain. Her findings show that the sex difference in Alzheimer’s disease is not because women live longer than men, as commonly thought, but rather because the disease starts earlier in the female brain. Her insights into these key transition states of the aging brain provide therapeutic opportunities to prevent, delay, and treat neurodegenerative disease.   More Information Read more about Dr. Roberta Diaz Brinton's research and scholarship. Learn more on the Brinton Lab Website. The Society for Neuroscience (SfN) is a well-known conference, drawing 28 thousand people annually. In contrast, AD Fast Track is a much smaller conference put on by BrightFocus, a foundation built to support AD and glaucoma research and awareness. Many of the speakers at the event were directly supported by BrightFocus (Lamb, Brinton, Head, Grinberg). Alzheimer's disease research is reinventing itself in the wake of past failures. New understandings of disease complexity, paired with recent advances in technology and a renewed surge in funding for research fuels new hope for a cure or treatment. Yet we aren't putting all our eggs in one basket. This series explores Alzheimer's disease research and the variety of research strategies with the common goal of curing Alzheimer's disease.   Any other questions?  Let us know!  We appreciate your feedback. You can now support the podcast at https://www.patreon.com/sfspodcast.  Many thanks to our past and present supporters!  Thanks to Plant Warrior for their support.  Use discount code SFS10 at checkout for 10% off your purchase of plant-based protein.

This week's episode features another throwback recorded in San Diego, CA, where Connor Wander attended the BrightFocus Alzheimer's Disease Fast Track conference, followed by the Society for Neuroscience annual meeting. We talked with Dr. Elizabeth Head, who studies the link between Down Syndrome and Alzheimer's disease with the hopes of improving lives for both patient classes. Listen to hear about this super interesting and very promising work!   About Dr. Elizabeth Head Dr. Elizabeth Head has recently moved from the University of Kentucky to the University of California, Irvine (UCI) and joined the UCI MIND institute. Dr. Head has published over 150 peer reviewed papers, over 30 review papers and book chapters and serves as a grant reviewer for the National Institutes on Health. Dr. Head has dedicated over 20 years to the study of aging and Alzheimer’s disease with a focus on people with Down Syndrome. Catch Dr. Head's livestream where she answers the question: "Are there any promising vaccines for Alzheimer's" on May 3rd, 2019.   More Information Learn more about The International Brain Bank for Down Syndrome-Related Alzheimer's disease mentioned in the podcast. Also watch a presentation by Dr. Head on how to improve quality of life in Down Syndrome and Alzheimer's disease.   The Society for Neuroscience (SfN) is a well-known conference, drawing 28 thousand people annually. In contrast, AD Fast Track is a much smaller conference put on by BrightFocus, a foundation built to support AD and glaucoma research and awareness. Many of the speakers at the event were directly supported by BrightFocus (Lamb, Brinton, Head, Grinberg). Alzheimer's disease research is reinventing itself in the wake of past failures. New understandings of disease complexity, paired with recent advances in technology and a renewed surge in funding for research fuels new hope for a cure or treatment. Yet we aren't putting all our eggs in one basket. This series explores Alzheimer's disease research and the variety of research strategies with the common goal of curing Alzheimer's disease.   Listen to our Alzheimer's Fast Track Series Ep. 39: Alzheimer’s Disease Research Part I with Drs. Diane Bovenkamp, Frank LaFerla, and Bruce Lamb Ep. 41: Alzheimer’s Disease Research roundtable with Drs. Cynthia Lemere, Charles Glabe, and Lea T. Grinberg   Any other questions?  Let us know!  We appreciate your feedback. You can now support the podcast at https://www.patreon.com/sfspodcast.  Many thanks to our past and present supporters!  Thanks to Plant Warrior for their support.  Use discount code SFS10 at checkout for 10% off your purchase of plant-based protein.

Our featured speaker is Goldis Malek, PhD, of Duke University. Dr. Malek's lab is focused on investigating the mechanisms underlying age-related macular degeneration, and to hopefully identify therapeutic targets for this debilitating degenerative eye disease.

James Keach has been a part of the film industry as an actor, director, writer, and producer. He has appeared in over fifty feature films and has produced and directed hundreds of hours of television. His most recent success was the award-winning documentary “Glen Campbell…I’ll Be Me,” which showed the legendary singer’s unprecedented “Goodbye Tour” after he was diagnosed with Alzheimer’s disease. James’ 2018 documentary feature film, “Augie,” tells the story of Augie Nieto, the genius entrepreneur and LifeFitness founder who was diagnosed with ALS over a decade ago and how he continues to work every day to find the cure for the disease. Before that, James has produced “Walk the Line,” for which the Producerʼs Guild of America nominated him Motion Picture Producer of the Year. The film was also nominated for several Academy and Golden Globe awards, winning the Golden Globe for Best Motion Picture and garnering Reese Witherspoon her Academy Award for Best Actress. On This Episode: A discussion of James’ gripping new documentary, “Turning Point.” The filmmaker takes us inside the quest for the first medication that could treat the underlying process of Alzheimer’s disease, more than a century after Dr. Alois Alzheimer first described the brain disorder that slowly destroys memory and cognitive skills. Along the way, we meet the people behind these grand experiments: the scientists driven as much by personal conviction as professional innovation. Twitter: @randallkjones @siriouslysusan @_BrightFocus @turning_point18 Instagram: @RandallKennethJones @SiriouslySusan @BrightFocus Facebook: https://www.facebook.com/TurningPointMovie2018/ Join us in the Jones.Show Lounge on Facebook www.RandallKennethJones.com www.SusanCBennett.com www.TurningPointMovie.com www.BrightFocus.org

The telephone discussion features Dr. Gayatri S. Reilly of The Retina Group of Washington, who has excelled in research, patient care, and educating other eye care professionals about treating diseases such as age-related macular degeneration (AMD).

The telephone discussion features Deirdre Johnston, MD, a geriatric psychiatrist at Johns Hopkins University.

This week’s episode marks the 2nd of a series focused on Alzheimer’s disease (AD) research.  All episodes were recorded in San Diego, CA, where Connor Wander attended the BrightFocus Alzheimer’s Disease Fast Track conference, followed by the Society for Neuroscience annual meeting. The Society for Neuroscience (SfN) is a well-known conference, drawing 28 thousand people annually.  In contrast, AD Fast Track is a much smaller conference put on by BrightFocus, a foundation built to support AD and glaucoma research and awareness.  Many of the speakers at the event were directly supported by BrightFocus (Lamb, Brinton, Head, Grinberg). Alzheimer’s disease research is reinventing itself in the wake of past failures.  New understandings of disease complexity, paired with recent advances in technology and a renewed surge in funding for research fuels new hope for a cure or treatment.  Yet we aren’t putting all our eggs in one basket.  This series will explore Alzheimer’s disease research and the variety of research strategies with the common goal of curing Alzheimer’s disease.   In This Episode Listen in to a roundtable with Drs. Cynthia Ann Lemere, Charles Glabe, and Lea T. Grinberg to learn about current research on the causes and possible treatments for Alzheimer's Disease.  We also discuss possible misrepresentations of the Amyloid cascade hypothesis, as well as applications of 3D printing in brain scan models. Special thanks to all podcasts guests and to Martha and Rachel from BrightFocus!   More Information Listen to a brief summary of Alzheimer’s disease signs and symptoms with Dr. Diane Bovenkamp. Find more quick chats on the BrightFocus Foundation website, including some tips and support for Alzheimer’s disease caregivers. The Amyloid cascade hypothesis is commonly discussed in Episode 41: Alzheimer’s disease roundtable. Listen to a discussion of Amyloid beta’s putative role as an ancient ant-microbial peptide in the brain in Episode 13: Amyloid Beta: Villain, or Hero in Alzheimer’s Disease? This possible role for Amyloid beta is important in the Amyloid cascade hypothesis; the idea that amyloid beta is the first thing to go wrong in AD, and triggers a chain reaction causing tau to aggregate and kill neurons.  This is a commonly discussed hypothesis in Alzheimer’s research, and is often referenced in this series. Learn more with a detailed infographic on the Amyloid cascade hypothesis.  It’s in a perspective piece discussing the recent developments in AD research by Biogen, and Eisai, two companies working on Alzheimer’s disease therapeutics like such as anti-amyloid or anti-tau antibodies, which have shown some promise in AD clinical trials. For more in-depth analysis of developments in AD and other neurodegenerative diseases, check out Alzforum.org for Alzheimer’s disease background reading. Read about and see images of protein maps in the human brain that help identify markers of brain disease.     Any other questions?  Let us know!  We appreciate your feedback. You can now support the podcast at https://www.patreon.com/sfspodcast.  Many thanks to our past and present supporters!  Thanks to Plant Warrior for their support.  Use discount code SFS10 at checkout for 10% off your purchase of plant-based protein.

The telephone discussion features Christopher Brittain, MB, BS, BSc (Hons), MBA, DIC, MRCOphth, who is Interim Global Head of Ophthalmology Clinical Development at Genentech.

This week’s episode marks the 1st of a series focused on Alzheimer’s disease (AD) research.  All episodes were recorded in San Diego, CA, where Connor Wander attended the BrightFocus Alzheimer’s Disease Fast Track conference, followed by the Society for Neuroscience annual meeting. The Society for Neuroscience (SfN) is a well-known conference, drawing 28 thousand people annually.  In contrast, AD Fast Track is a much smaller conference put on by BrightFocus, a foundation built to support AD and glaucoma research and awareness.  Many of the speakers at the event were directly supported by BrightFocus (Lamb, Brinton, Head, Grinberg). Alzheimer’s disease research is reinventing itself in the wake of past failures.  New understandings of disease complexity, paired with recent advances in technology and a renewed surge in funding for research fuels new hope for a cure or treatment.  Yet we aren’t putting all our eggs in one basket.  This series will explore Alzheimer’s disease research and the variety of research strategies with the common goal of curing Alzheimer’s disease.   In This Episode Listen in to hear an overview of the BrightFocus AD Fast Track conference and current standing of Alzheimer’s disease research.  We also focus on animal models of Alzheimer’s disease. @6:07 Dr. Diane Bovenkamp introduces BrightFocus and the AD Fast Track Conference. @21:00 Dr. Frank LaFerla breaks down amyloid beta and tau in Alzheimer's disease research. @37:31 Dr. Bruce T. Lamb describes the MODEL-AD project, which seeks to better simulate Alzheimer's disease in animal models. Special thanks to all podcasts guests and to Martha and Rachel from BrightFocus!     More Information Listen to a brief summary of Alzheimer’s disease signs and symptoms with Dr. Diane Bovenkamp. Find more quick chats on the BrightFocus Foundation website, including some tips and support for Alzheimer’s disease caregivers. The amyloid cascade hypothesis is commonly discussed in Episode 41: Alzheimer’s disease roundtable. Listen to a discussion of Amyloid beta’s putative role as an ancient ant-microbial peptide in the brain in Episode 13: Amyloid Beta: Villain, or Hero in Alzheimer’s Disease? This possible role for Amyloid beta is important in the Amyloid cascade hypothesis; the idea that amyloid beta is the first thing to go wrong in AD, and triggers a chain reaction causing tau to aggregate and kill neurons.  This is a commonly discussed hypothesis in Alzheimer’s research, and is often referenced in this series. Learn more with a detailed infographic on the Amyloid cascade hypothesis.  It’s in a perspective piece discussing the recent developments in AD research by Biogen, and Eisai, two companies working on Alzheimer’s disease therapeutics like such as anti-amyloid or anti-tau antibodies, which have shown some promise in AD clinical trials. For more in-depth analysis of developments in AD and other neurodegenerative diseases, check out Alzforum.org for Alzheimer’s disease background reading.     Any other questions?  Let us know!  We appreciate your feedback. You can now support the podcast at https://www.patreon.com/sfspodcast.  Many thanks to our past and present supporters!  Thanks to Plant Warrior for their support.  Use discount code SFS10 at checkout for 10% off your purchase of plant-based protein.

The telephone discussion features Dr. Joshua Dunaief, of the University of Pennsylvania’s Perelman School of Medicine, who specializes in the study of age-related macular degeneration.

Priyatham S. Mettu, MD, is a Duke University retina specialist who is testing new treatments and new imaging technologies for age-related macular degeneration.

The telephone discussion features Sheldon Rowan, PhD of the USDA Human Nutrition Research Center on Aging, Tufts University. Dr. Rowan’s research examines the impact of dietary carbohydrate quality on age-related macular degeneration.

Ranjoo K. Prasad, O.D., a specialist in low vision rehabilitation at Penn Medicine, is the guest speaker.

The telephone discussion features Dr. Joshua Dunaief, of the University of Pennsylvania’s Perelman School Medicine, who specializes in the study of age-related macular degeneration.

The guest speakers are Sara Brown and Dan Roberts from Prevent Blindness who discuss eye health advocacy.

The guest speaker is Priyatham S. Mettu, MD, a Duke University retina specialist who is testing new treatments and new imaging technologies for age-related macular degeneration.

The speaker was Dr. William Li, President of The Angiogenesis Foundation, and his guests: Leona, a person living with macular degeneration, and her daughter, Sharon, who provided their perspectives on managing this eye disease.

The telephone discussion features Dr. Gayatri S. Reilly of The Retina Group of Washington, who has excelled in research, patient care, and educating other eye care professionals about treating diseases such as age-related macular degeneration (AMD).

The telephone discussion features Dr. Gayatri S. Reilly of The Retina Group of Washington, who has excelled in research, patient care, and educating other eye care professionals about treating diseases such as age-related macular degeneration (AMD).

Allen Taylor, PhD directs the Laboratory for Nutrition and Vision Research at Tufts (a part of the USDA Human Nutrition Research Center on Aging), and also holds faculty positions in nutrition, ophthalmology, molecular & chemical biology, and development at the Tufts University School of Medicine. He talks about how age-related macular degeneration (AMD) develops, the nutritional component, and what new research shows about ways to delay onset or progress.

This telephone discussion features Orli Weisser-Pike, a doctor of occupational therapy and a certified low vision therapist. She has over eighteen years of clinical experience in a wide variety of settings and has for the past decade specialized in treating people disabled by vision loss.

This telephone discussion features Orli Weisser-Pike, a doctor of occupational therapy and a certified low vision therapist. She has over eighteen years of clinical experience in a wide variety of settings and has for the past decade specialized in treating people disabled by vision loss.

The guest speakers are Alfred S. Lewin, PhD, from the University of Florida Department of Molecular Genetics and Microbiology, who focuses on developing therapies for inherited and age-related diseases of the retina; and Manas Biswal, PhD, a Postdoctoral Associate, also from the University of Florida.

Ranjoo K. Prasad, O.D., a specialist in low vision rehabilitation at Penn Medicine, is the guest speaker.

Milam A. Brantley, MD, PhD, of the Vanderbilt Eye Institute, answers questions about macular degeneration, a leading cause of vision loss in Americans 60 years of age and older.

The telephone discussion features Dr. Gayatri S. Reilly of The Retina Group of Washington, who has excelled in research, patient care, and educating other eye care professionals about treating diseases such as age-related macular degeneration (AMD).

The telephone discussion features Dr. Joshua Dunaief, of the University of Pennsylvania’s Perelman School of Medicine, who specializes in the study of age-related macular degeneration.

Dr. Ward Bond, who regularly appears in the media and before public audiences, discusses the vital role of nutrition in reducing the risk and progression of age-related diseases such as macular degeneration and glaucoma.

Dr. Ward Bond, who regularly appears in the media and before public audiences, discusses the vital role of nutrition in reducing the risk and progression of age-related diseases such as macular degeneration and glaucoma.

The guest speakers are Sandra S. Block, OD and Christina Morettin, OD.Sandra Block, OD is a professor at the Illinois College of Optometry and was part of a National Academy of Sciences study, "Making Eye Health a Population Imperative: Vision for Tomorrow."Christina Morettin, OD is an assistant professor at the Illinois College of Optometry, and chief of Urgent Eye Care Services. Her interests include urgent eye care, primary eye care, ocular disease, including retinal disease.

The telephone discussion features Dr. Joshua Dunaief, of the University of Pennsylvania’s Perelman School of Medicine, who specializes in the study of age-related macular degeneration.

The guest speaker is Stephen Azman, who is Director of Patient Care at Low Vision Specialists of Maryland and Virginia (LVS), a group that specializes in maximizing patient vision and customizing optical systems for adults and geriatric patients suffering from vision loss.

Gerard "Jerry" Lutty, PhD and Imran Bhutto, MD, PhD of the Wilmer Ophthalmological Institute at Johns Hopkins University are the featured speakers.

The guest speaker is Tim Corson, PhD, an assistant professor in the Department of Ophthalmology, Biochemistry and Molecular Biology, and the Department of Pharmacology and Toxicology, at Indiana University School of Medicine. He is working on developing new therapies for diseases of abnormal blood vessel growth such as age-related macular degeneration.

Ranjoo K. Prasad, OD, a specialist in low vision rehabilitation at Penn Medicine, is the guest speaker.

The featured speaker is Dan Dunbar, who was legally blind from macular degeneration and had some restoration of vision after having a tiny telescope implanted into his eye.

Milam A. Brantley, Jr., MD, PhD, of the Vanderbilt Eye Institute, discusses the type of doctor that is most appropriate for monitoring and treating the wet and dry forms of age-related macular degeneration.

Orli Weisser-Pike, a doctor of occupational therapy and a certified low vision therapist is the guest speaker. She has over eighteen years of clinical experience in a wide variety of settings and has for the past decade specialized in helping people affected by low vision.

The guest speaker is Michael Allingham, MD, PhD, who is an ophthalmologist at Duke University.

Adam S. Wenick, M.D., Ph.D., who is an assistant professor of ophthalmology in the retina division at Johns Hopkins Wilmer Eye Institute is the guest speaker.

The phone conference features Brian S. McKay, PhD, who conducts basic research towards developing new cell-based therapies for macular degeneration. He discusses a major new breakthrough showing that L-DOPA, a drug widely used to treat Parkinson’s disease, may help protect against age-related macular degeneration (AMD); Maria B. Grant, MD, who conducts research using adult stem cells to repair damaged blood vessel networks within the retina that are associated with macular degeneration; and David Pepperberg, PhD, who researches methods to restore vision lost in diseases such as age-related macular degeneration.

This telephone discussion features Christopher Brady, MD, an ophthalmologist from the Wilmer Eye Institute at Johns Hopkins University School of Medicine, who specializes in the medical and surgical management of retinal diseases, including macular degeneration. His research focuses on the benefits of telemedicine for underserved populations and how new technologies can improve patient care.

This telephone discussion features Priyatham (Prithu) S. Mettu, M.D., from the Duke Center for Macular Diseases, who provides helpful information for those recently diagnosed with macular degeneration.

The telephone discussion features Robert W. Massof, PhD, who is Professor of Ophthalmology and Neuroscience at the Johns Hopkins University School of Medicine and Director of the Lions Vision Research and Rehabilitation Center and the Johns Hopkins Wilmer Eye Institute, and Jim Deremeik, RT, CLVT, who is the LOVRNET Project Manager and the Education/Rehabilitation Program Manager for the Lions Vision Research and Rehabilitation Center at the Johns Hopkins Wilmer Eye Institute.

The telephone discussion features Jim Hindman, founder of Jiffy Lube International, who was diagnosed with age-related macular degeneration at age 57 and years later declared legally blind. He refused to give up hope, eventually finding his way out of the darkness with the IMT (implantable miniature telescope).

This telephone discussion features Dr. Jacque Duncan, an ophthalmologist at UCSF Medical Center, who specializes in treating retina degenerations such as retinitis pigmentosa and age-related macular degeneration.

This telephone discussion features Albert O. Edwards, MD, PhD, a board certified ophthalmologist specializing in diseases and surgery of the retina.

The Talking Information Center interviews Dr. Guy Eakin, Vice President of Scientific Affairs at BrightFocus Foundation, about the mission of the organization and the new BrightFocus Chats telephone discussions on macular degeneration.

The Talking Information Center interviews Dr. Guy Eakin, Vice President of Scientific Affairs at BrightFocus Foundation, about the mission of the organization and the new BrightFocus Chats telephone discussions on macular degeneration.

This telephone discussion features Milam A. Brantley, Jr., M.D., Ph.D., of the Vanderbilt Eye Institute, on the latest research findings and their implications for treatment; and a patient advocate, on living with macular degeneration.

In this audio presentation, Dr. Guy Eakin, Vice President of Scientific Affairs for BrightFocus Foundation, discusses the top five questions you should ask your doctor regarding your macular degeneration diagnosis

Dr. Guy Eakin, Vice President of Scientific Affairs for the BrightFocus Foundation, discusses the top five questions you should ask your doctor regarding your Alzheimer's diagnosis.

Dr. Diane Bovenkamp, Science Communications Specialist at BrightFocus, provides an overview of macular degeneration, a leading cause of vision loss in Americans 60 and older, and the second-highest cause of irreversible visual impairment in the world.